Literature DB >> 19332108

Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neuropathic pain after spinal injury in rat.

Y S Gwak1, C E Hulsebosch.   

Abstract

In this study, we evaluated whether astrocytic and microglial activation mediates below-level neuropathic pain following spinal cord injury. Male Sprague-Dawley (225-250 g) rats were given low thoracic (T13) spinal transverse hemisection and behavioral, electrophysiological and immunohistochemical methods were used to examine the development and maintenance of below-level neuropathic pain. On postoperation day 28, both hind limbs showed significantly decreased paw withdrawal thresholds and thermal latencies as well as hyperexcitability of lumbar (L4-5) spinal wide dynamic range (WDR) neurons on both sides of spinal dorsal horn compared to sham controls (* P<0.05). Intrathecal treatment with propentofylline (PPF, 10 mM) for 7 consecutive days immediately after spinal injury attenuated the development of mechanical allodynia and thermal hyperalgesia in both hind limbs in a dose-related reduction compared to vehicle treatments (* P<0.05). Intrathecal treatment with single injections of PPF at 28 days after spinal injury, attenuated the existing mechanical allodynia and thermal hyperalgesia in both hind limbs in a dose related reduction (* P<0.05). In electrophysiological studies, topical treatment of 10 mM PPF onto the spinal surface attenuated the neuronal hyperexcitability in response to mechanical stimuli. In immunohistochemical studies, astrocytes and microglia in rats with spinal hemisection showed significantly increased GFAP and OX-42 expression in both superficial and deep dorsal horns in the lumbar spinal dorsal horn compared to sham controls (* P<0.05) that was prevented in a dose-related manner by PPF. In conclusion, our present data support astrocytic and microglial activation that contributes to below-level central neuropathic pain following spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332108      PMCID: PMC3005301          DOI: 10.1016/j.neuroscience.2009.03.055

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  44 in total

Review 1.  Spinal cord glia: new players in pain.

Authors:  L R Watkins; E D Milligan; S F Maier
Journal:  Pain       Date:  2001-09       Impact factor: 6.961

Review 2.  Synthesis and release of neuroactive substances by glial cells.

Authors:  D L Martin
Journal:  Glia       Date:  1992       Impact factor: 7.452

3.  Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate.

Authors:  D Piani; K Frei; K Q Do; M Cuénod; A Fontana
Journal:  Neurosci Lett       Date:  1991-12-09       Impact factor: 3.046

Review 4.  Modulation of pH by neuronal activity.

Authors:  M Chesler; K Kaila
Journal:  Trends Neurosci       Date:  1992-10       Impact factor: 13.837

5.  Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury.

Authors:  C J Garrison; P M Dougherty; K C Kajander; S M Carlton
Journal:  Brain Res       Date:  1991-11-22       Impact factor: 3.252

Review 6.  Role of glial cells in the regulation of the brain ion microenvironment.

Authors:  W Walz
Journal:  Prog Neurobiol       Date:  1989       Impact factor: 11.685

7.  Changes in dorsal horn synaptic disc numbers following unilateral dorsal rhizotomy.

Authors:  K Chung; D L McNeill; C E Hulsebosch; R E Coggeshall
Journal:  J Comp Neurol       Date:  1989-05-22       Impact factor: 3.215

8.  Detection of superoxide production by activated microglia using a sensitive and specific chemiluminescence assay and microglia-mediated PC12h cell death.

Authors:  M Tanaka; A Sotomatsu; T Yoshida; S Hirai; A Nishida
Journal:  J Neurochem       Date:  1994-07       Impact factor: 5.372

9.  Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines.

Authors:  D Piani; M Spranger; K Frei; A Schaffner; A Fontana
Journal:  Eur J Immunol       Date:  1992-09       Impact factor: 5.532

10.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

Authors:  G J Bennett; Y K Xie
Journal:  Pain       Date:  1988-04       Impact factor: 6.961

View more
  57 in total

1.  Below level central pain induced by discrete dorsal spinal cord injury.

Authors:  Julie Wieseler; Amanda L Ellis; Andrew McFadden; Kimberley Brown; Charlotte Starnes; Steven F Maier; Linda R Watkins; Scott Falci
Journal:  J Neurotrauma       Date:  2010-09       Impact factor: 5.269

2.  Validity of acute and chronic tactile sensory testing after spinal cord injury in rats.

Authors:  Megan Ryan Detloff; Leslie M Clark; Karen J Hutchinson; Anne D Kloos; Lesley C Fisher; D Michele Basso
Journal:  Exp Neurol       Date:  2010-07-17       Impact factor: 5.330

Review 3.  Preclinical models of muscle spasticity: valuable tools in the development of novel treatment for neurological diseases and conditions.

Authors:  Anton Bespalov; Liudmila Mus; Edwin Zvartau
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02-10       Impact factor: 3.000

4.  Herpes simplex virus vector-mediated expression of interleukin-10 reduces below-level central neuropathic pain after spinal cord injury.

Authors:  Darryl Lau; Steven E Harte; Thomas J Morrow; Shiyong Wang; Marina Mata; David J Fink
Journal:  Neurorehabil Neural Repair       Date:  2012-05-15       Impact factor: 3.919

5.  Chronic spontaneous activity generated in the somata of primary nociceptors is associated with pain-related behavior after spinal cord injury.

Authors:  Supinder S Bedi; Qing Yang; Robyn J Crook; Junhui Du; Zizhen Wu; Harvey M Fishman; Raymond J Grill; Susan M Carlton; Edgar T Walters
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

6.  Nor-Binaltorphimine Blocks the Adverse Effects of Morphine after Spinal Cord Injury.

Authors:  Miriam Aceves; Eric A Bancroft; Alejandro R Aceves; Michelle A Hook
Journal:  J Neurotrauma       Date:  2016-11-04       Impact factor: 5.269

7.  Gp120 in the pathogenesis of human immunodeficiency virus-associated pain.

Authors:  Su-Bo Yuan; Yuqiang Shi; Jinghong Chen; Xiangfu Zhou; Guangyu Li; Benjamin B Gelman; Joshua G Lisinicchia; Susan M Carlton; Monique R Ferguson; Alai Tan; Sushil K Sarna; Shao-Jun Tang
Journal:  Ann Neurol       Date:  2014-05-28       Impact factor: 10.422

8.  Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain.

Authors:  Amanda Ellis; Julie Wieseler; Jacob Favret; Kirk W Johnson; Kenner C Rice; Steven F Maier; Scott Falci; Linda R Watkins
Journal:  J Pain       Date:  2014-01-09       Impact factor: 5.820

9.  Glutamate-mediated astrocyte-to-neuron signalling in the rat dorsal horn.

Authors:  Rita Bardoni; Alessia Ghirri; Micaela Zonta; Chiara Betelli; Giovanni Vitale; Valentina Ruggieri; Maurizio Sandrini; Giorgio Carmignoto
Journal:  J Physiol       Date:  2010-01-18       Impact factor: 5.182

10.  Activation of p-38alpha MAPK contributes to neuronal hyperexcitability in caudal regions remote from spinal cord injury.

Authors:  Young S Gwak; Geda C Unabia; Claire E Hulsebosch
Journal:  Exp Neurol       Date:  2009-08-20       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.